Pre-made Ensomafusp Alfa benchmark antibody (Bispecific, anti-CD19;TNFRSF9 therapeutic antibody, Anti-B4/CVID3;ILA/4-1BB/CDw137 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-836

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-836 Category Tag

Product Details

Pre-made Ensomafusp Alfa benchmark antibody (Bispecific, anti-CD19;TNFRSF9 therapeutic antibody, Anti-B4/CVID3;ILA/4-1BB/CDw137 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Ensomafusp Alfa Alfaiosimilar, Bispecific, Anti-Cd19; Tnfrsf9 Antibody: Anti-B4/CVID3;ILA/4-1BB/CDw137 therapeutic antibody

INN Name

ensomafusp alfa

Target

CD19

Format

Bispecific

Derivation

NA

Species Reactivity

NA

CH1 Isotype

NA

VD LC

NA

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

NA

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

CD19,TNFRSF9

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide